MRI and MEG imaging of human sensory disorders
Professor Susan Francis of the Sir Peter Mansfield Imaging Centre, University of Nottingham explores how state-of-the-art imaging methods can be used to study human...
The role of geography in addressing global health needs
Senior Research Advisor from the American Association of Geographers, Yonette Thomas discusses the important role that geography can play in addressing global health needs,...
Sam Gyimah announces £70 million funding to help develop new medical treatments
Industrial strategy boost will help speed up the development of new medical treatments with £70 million funding
The £70 million of funding will be used...
Implementing digital technology for brain health
Frédéric Destrebecq, Vinciane Quoidbach and Marijn Scholte from The European Brain Council (EBC) detail how the future of healthcare and improved brain health can...
Understanding mental health – through our stomachs
Alex Schubert from the European College of Neuropsychopharmacology (ECNP) explores the link between our mental health and what we eat
Every day we consume a...
AAV: From almost a virus to an awesome vector for human gene therapy
Dr. Arun Srivastava, George H. Kitzman Professor of Genetics, from the University of Florida describes the rationale and strategies for the development of next...
Acute myeloid leukaemia (AML)
Acute myeloid leukaemia (AML), a form of blood cancer is placed into the spotlight by Open Access Government
Acute myeloid leukaemia (AML) is a form...
Ground-breaking results for Huntington’s Disease (HD) research
Svein Olaf Olsen and Maiken Arnesen from the European Huntington Association reveal their thoughts on a recent and significant breakthrough concerning Huntington’s Disease (HD)...
Pernicious Anaemia: The world’s forgotten disease
Chairman of The Pernicious Anaemia Society, Martyn Hooper MBE lifts the lid on the history, causes and diagnosis of the world’s forgotten disease
From the...
The Finnish Allergy Programme 2008-2018: Reducing the burden of allergy in both patients and...
Managing director of the Finnish Allergy, Skin and Asthma Federation, Ilkka Repo explores The Finnish Allergy Programme 2008-2018 and what it sets out to...
RELEVANCE of red blood cells and why do we care about them
Anna Bogdanova from University of Zurich lifts the lid on the vital role of red blood cells in keeping the human brain running and...
Technology interventions to address dyspnoea: Point-of-care lung ultrasonography
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group highlights technology interventions that address dyspnoea – focussing on point-of-care lung ultrasonography
The Murray and Nadel’s...
An emerging environmental health concern: Impacts of air pollution on the brain
Anthony S. Wexler and Pamela J. Lein from the University of California share their expert views on the impacts of air pollution on the...
Moving towards clinical applications of genomics (The TrainMALTA project)
Rosienne Farrugia from the University of Malta explores the role of high throughput sequencing (HTS) in rare and complex diseases, including the move towards...
From Rwanda into the clinical pharmacy in the Palatinate
As part of their partnership, Rhineland-Palatinate region of Germany and Rwanda foster the exchange of knowledge in hospital management, medical professions and psychiatric care...
Report reveals flaws and human rights challenges in European mental health systems
Mental Health Europe and the University of Kent-Tizard Centre have launched a new report which has revealed the flaws and human rights challenges in...
The broad and diverse medical technology sector
Jonathan Evans, communications manager at the Association of British Healthcare Industries explores the broad and diverse MedTech sector as it stands today
The Medical Technology...
For malaria progress: The bottom line IS the bottom line
David H Peyton. Ph.D., Professor of Chemistry at Portland State University explores the progress being made on malaria in the world today
The annual report...
IDEAS: improving design, evaluation and analysis of early drug development studies
Prof Thomas Jaki from the Medical and Pharmaceutical Statistics Research Unit at Lancaster University explores a novel approach to Ph.D. training for those in the pharmaceutical industry
Chronic kidney disease – advancing opportunities for personalised treatment
Cecilia Van Cauwenberghe from Frost & Sullivan explores advancing opportunities for personalised treatment of chronic kidney disease (CKD) and research into membranous nephropathy (MN)
According...